The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study

被引：0
|
作者：
Alessia Melegaro
Valentina Marziano
Emanuele Del Fava
Piero Poletti
Marcello Tirani
Caterina Rizzo
Stefano Merler
机构：
[1] Bocconi University,Department of Social and Political Sciences
[2] Bocconi University,Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy
[3] Center for Information and Communication Technology,undefined
[4] Bruno Kessler Foundation,undefined
[5] Department of Hygiene and Preventive Medicine,undefined
[6] ATS,undefined
[7] Department of Infectious Disease,undefined
[8] Istituto Superiore di Sanità,undefined
来源：
BMC Medicine | / 16卷
关键词：
Varicella; Chickenpox; Herpes zoster; Shingles; Vaccination; Italy; Cost-effectiveness; Modelling; Individual-based models; Demography; Immunisation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONS
    Coretti, Silvia
    Codella, Paola
    Romano, Federica
    Ruggeri, Matteo
    Cicchetti, Americo
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (04) : 233 - 240
  • [32] Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster
    Littlewood, Kavi J.
    Ouwens, Mario J. N. M.
    Sauboin, Christophe
    Tehard, Bertrand
    Alain, Sophie
    Denis, Francois
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 830 - 841
  • [33] Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
    de Boer, Pieter T.
    van Lier, Alies
    de Melker, Hester
    van Wijck, Albert J. M.
    Wilschut, Jan C.
    van Hoek, Albert Jan
    Postma, Maarten J.
    BMC MEDICINE, 2018, 16
  • [34] The Cost-effectiveness of Varicella Zoster Virus Vaccination Considering Late Onset Asthma
    Ditkowsky, Jared
    Kohlhoff, Stephan
    Smith-Norowitz, Tamar A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (09) : E275 - E284
  • [35] The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
    Brisson, Marc
    Pellissier, James M.
    Camden, Stephanie
    Quach, Caroline
    De Wals, Philippe
    HUMAN VACCINES, 2008, 4 (03): : 238 - 245
  • [36] Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study
    Mwenda, Valerian
    Jalang'o, Rose
    Miano, Christine
    Bor, Joan-Paula
    Nyangasi, Mary
    Mecca, Lucy
    Were, Vincent
    Kariithi, Edward
    Pecenka, Clint
    Schuind, Anne
    Abbas, Kaja
    Clark, Andrew
    VACCINE, 2023, 41 (29) : 4228 - 4238
  • [37] Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany
    Preaud, Emmanuelle
    Uhart, Mathieu
    Boehm, Katharina
    Aidelsburger, Pamela
    Anger, Delphine
    Bianic, Florence
    Largeron, Nathalie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 884 - 896
  • [38] Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom
    Akpo, Esse Ifebi Herve
    Cristeau, Olivier
    Hunjan, Manjit
    Casabona, Giacomo
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3617 - E3626
  • [39] Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan
    Hoshi, Shu-ling
    Seposo, Xerxes
    Shono, Aiko
    Okubo, Ichiro
    Kondo, Masahide
    VACCINE, 2019, 37 (27) : 3588 - 3597
  • [40] Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
    Alies van Lier
    Albert Jan van Hoek
    Wim Opstelten
    Hein J Boot
    Hester E de Melker
    BMC Health Services Research, 10
12345